Literature DB >> 20154628

Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children.

Ned Calonge1, Nancy S Green, Piero Rinaldo, Michele Lloyd-Puryear, Denise Dougherty, Coleen Boyle, Michael Watson, Tracy Trotter, Sharon F Terry, R Rodney Howell.   

Abstract

The Secretary's Advisory Committee on Heritable Disorders in Newborns and Children is charged with evaluating conditions nominated for addition to the uniform screening panel and consequently making recommendations to the secretary of the US Department of Health and Human Services. This report describes the framework by which the committee approaches its task. Key decision nodes include initial review of every nomination to determine whether conditions are amenable for systematic evidence review, review of systematic evidence reviews conducted by the committee's external review group, and deliberation and formal recommendation for addition or exclusion to the uniform panel. Data analyzed include the accuracy and specificity of screening and diagnostic tests for nominated disorders, the extent of predicted health benefits, harms impact on disease course, and cost from early diagnosis and treatment. The committee process is guided by approaches used by similar entities, but more flexible criteria are sometimes needed to accommodate data limitations stemming from the rarity of many of these conditions. Possible outcomes of committee review range from recommendation to add a nominated condition to the uniform panel; provide feedback on specific gaps in evidence that must be addressed before making a decision; or rejection of a nomination (e.g., because of identified harms). The committee's structured evidence-based assessment of nominated conditions supports a consistently rigorous, iterative and transparent approach to its making recommendations regarding broad population-based screening programs for rare conditions in infants and children.

Entities:  

Mesh:

Year:  2010        PMID: 20154628     DOI: 10.1097/GIM.0b013e3181d2af04

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  30 in total

1.  Design and evaluation of a decision aid for inviting parents to participate in a fragile X newborn screening pilot study.

Authors:  Donald B Bailey; Megan A Lewis; Shelly L Harris; Tracey Grant; Carla Bann; Ellen Bishop; Myra Roche; Sonia Guarda; Leah Barnum; Cynthia Powell; Bradford L Therrell
Journal:  J Genet Couns       Date:  2012-06-27       Impact factor: 2.537

2.  Newborn Screening for Biliary Atresia.

Authors:  Kasper S Wang
Journal:  Pediatrics       Date:  2015-12       Impact factor: 7.124

Review 3.  Inborn errors of metabolism in the 21st century: past to present.

Authors:  Georgianne L Arnold
Journal:  Ann Transl Med       Date:  2018-12

Review 4.  International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents.

Authors:  Marleen E Jansen; Selina C Metternick-Jones; Karla J Lister
Journal:  Eur J Hum Genet       Date:  2016-11-16       Impact factor: 4.246

Review 5.  Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?

Authors:  Michael J Cannon; Paul D Griffiths; Van Aston; William D Rawlinson
Journal:  Rev Med Virol       Date:  2014-04-24       Impact factor: 6.989

6.  The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.

Authors:  Scott D Grosse; John D Thompson; Yao Ding; Michael Glass
Journal:  Milbank Q       Date:  2016-06       Impact factor: 4.911

7.  Biobank participant support of newborn screening for disorders with variable treatment and intervention options.

Authors:  Megan E Bunnell; Beth A Tarini; Michael Petros; Aaron J Goldenberg; Aishwarya Arjunan; Catherine Wicklund
Journal:  J Community Genet       Date:  2016-09-01

8.  Genetics professionals' opinions of whole-genome sequencing in the newborn period.

Authors:  Elizabeth Ulm; W Gregory Feero; Richard Dineen; Joel Charrow; Catherine Wicklund
Journal:  J Genet Couns       Date:  2014-10-28       Impact factor: 2.537

Review 9.  Essential genetic and genomic nursing competencies for the oncology nurse.

Authors:  Jean Jenkins
Journal:  Semin Oncol Nurs       Date:  2011-02       Impact factor: 2.315

10.  Expectations and values about expanded newborn screening: a public engagement study.

Authors:  Robin Z Hayeems; Fiona A Miller; Yvonne Bombard; Denise Avard; June Carroll; Brenda Wilson; Julian Little; Pranesh Chakraborty; Jessica Bytautas; Yves Giguere; Judith Allanson; Renata Axler
Journal:  Health Expect       Date:  2013-02-01       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.